Two Sigma Advisers
TEVA icon

Two Sigma Advisers’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.89M Sell
232,100
-99,400
-30% -$1.67M 0.01% 833
2025
Q1
$5.1M Sell
331,500
-1,299,100
-80% -$20M 0.01% 784
2024
Q4
$35.9M Buy
1,630,600
+596,100
+58% +$13.1M 0.08% 208
2024
Q3
$18.6M Buy
1,034,500
+137,000
+15% +$2.47M 0.04% 334
2024
Q2
$14.6M Sell
897,500
-50,000
-5% -$813K 0.03% 427
2024
Q1
$13.4M Sell
947,500
-66,800
-7% -$943K 0.03% 440
2023
Q4
$10.6M Sell
1,014,300
-28,900
-3% -$302K 0.02% 509
2023
Q3
$10.6M Sell
1,043,200
-230,600
-18% -$2.35M 0.03% 451
2023
Q2
$9.59M Sell
1,273,800
-176,200
-12% -$1.33M 0.02% 503
2023
Q1
$12.8M Sell
1,450,000
-1,110,500
-43% -$9.83M 0.03% 464
2022
Q4
$23.4M Sell
2,560,500
-139,800
-5% -$1.27M 0.07% 296
2022
Q3
$21.8M Buy
2,700,300
+1,344,100
+99% +$10.8M 0.06% 302
2022
Q2
$10.2M Sell
1,356,200
-102,600
-7% -$772K 0.03% 498
2022
Q1
$13.7M Buy
1,458,800
+92,300
+7% +$867K 0.04% 411
2021
Q4
$10.9M Buy
1,366,500
+1,134,600
+489% +$9.09M 0.03% 481
2021
Q3
$2.26M Buy
+231,900
New +$2.26M 0.01% 1184
2021
Q2
Sell
-333,200
Closed -$3.85M 2691
2021
Q1
$3.85M Sell
333,200
-163,900
-33% -$1.89M 0.01% 964
2020
Q4
$4.8M Sell
497,100
-244,000
-33% -$2.35M 0.01% 837
2020
Q3
$6.68M Sell
741,100
-278,500
-27% -$2.51M 0.02% 664
2020
Q2
$12.6M Sell
1,019,600
-1,039,100
-50% -$12.8M 0.04% 470
2020
Q1
$18.5M Buy
2,058,700
+904,800
+78% +$8.13M 0.07% 309
2019
Q4
$11.3M Buy
+1,153,900
New +$11.3M 0.03% 560
2019
Q2
Sell
-194,399
Closed -$3.05M 2432
2019
Q1
$3.05M Buy
194,399
+22,599
+13% +$354K 0.01% 1035
2018
Q4
$2.65M Sell
171,800
-193,299
-53% -$2.98M 0.01% 1051
2018
Q3
$7.86M Sell
365,099
-3,002,500
-89% -$64.7M 0.02% 657
2018
Q2
$81.9M Sell
3,367,599
-503,400
-13% -$12.2M 0.22% 120
2018
Q1
$66.2M Sell
3,870,999
-2,381,600
-38% -$40.7M 0.18% 154
2017
Q4
$118M Buy
+6,252,599
New +$118M 0.32% 80
2017
Q3
Sell
-121,499
Closed -$4.04M 2348
2017
Q2
$4.04M Sell
121,499
-4,482,200
-97% -$149M 0.01% 845
2017
Q1
$148M Buy
4,603,699
+837,100
+22% +$26.9M 0.48% 32
2016
Q4
$137M Buy
3,766,599
+2,849,900
+311% +$103M 0.52% 37
2016
Q3
$42.2M Sell
916,699
-1,450,900
-61% -$66.8M 0.18% 132
2016
Q2
$119M Buy
2,367,599
+882,100
+59% +$44.3M 0.6% 31
2016
Q1
$79.5M Buy
1,485,499
+1,354,200
+1,031% +$72.5M 0.44% 53
2015
Q4
$8.62M Sell
131,299
-1,215,100
-90% -$79.8M 0.05% 347
2015
Q3
$76M Sell
1,346,399
-64,801
-5% -$3.66M 0.48% 55
2015
Q2
$83.4M Buy
1,411,200
+2,500
+0.2% +$148K 0.62% 21
2015
Q1
$87.8M Buy
1,408,700
+1,072,600
+319% +$66.8M 0.65% 19
2014
Q4
$19.3M Buy
336,100
+57,900
+21% +$3.33M 0.15% 172
2014
Q3
$15M Buy
278,200
+259,140
+1,360% +$13.9M 0.11% 212
2014
Q2
$999K Buy
+19,060
New +$999K 0.01% 1006
2014
Q1
Sell
-42,300
Closed -$1.7M 1962
2013
Q4
$1.7M Buy
+42,300
New +$1.7M 0.02% 670
2013
Q3
Sell
-88,200
Closed -$3.46M 1805
2013
Q2
$3.46M Buy
+88,200
New +$3.46M 0.05% 302